Is the new price of dabrafenib high after medical insurance?

Dabrafenib (Dabrafenib) belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that signals cancer cells to multiply, which helps stop their spread.

Dabrafenib is used alone or in combination with trametinib to treat certain types of melanoma (a type of skin cancer) and to prevent certain types of melanoma from coming back after surgery. Dabrafenibis also used in combination with tramatinib to treat certain types of non-small cell lung cancer (NSCLC) and thyroid cancer. It is also used in combination with tramatinib to treat certain types of solid tumors in adults and children 6 years or older, and to treat certain types of glioma (a type of cancerous brain tumor) in children 1 year or older.

The original drug of dabrafenib is relatively expensive and has entered the scope of medical insurance after being launched in China. Currently only eligible patients can be reimbursed. SpecificationsThe price per box of 50mg*120 pills may be around 10,000. The reimbursement ratio is different in different regions. The price after reimbursement may be slightly different, but it will be much lower than the original price. Patients can learn more about it when purchasing the drug at local hospitals or pharmacies.

The Turkish version of the original drug Dabrafenib sold overseas, Specifications 75mg*120 capsules, may cost around 10,000 per box (the price may fluctuate due to exchange rates). There are also relatively cheap generics of dabrafenib sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, Specifications produced by Laos Pharmaceutical Factory The price of 75mg*120 tablets per box may be more than 4,000 yuan (the price may fluctuate due to exchange rates).